Company profile for CSL Vifor

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

At Vifor Pharma, we are dedicated to finding the right treatment solutions for patients. Over several decades, we have proven our ability to identify and serve therapeutic areas with significant unmet medical need, successfully building on our expertise and track record to create new markets. We have a strong and rapidly growing presence in nephrology, and we are committed to launching the next generation of therapies to truly...
At Vifor Pharma, we are dedicated to finding the right treatment solutions for patients. Over several decades, we have proven our ability to identify and serve therapeutic areas with significant unmet medical need, successfully building on our expertise and track record to create new markets. We have a strong and rapidly growing presence in nephrology, and we are committed to launching the next generation of therapies to truly address the full spectrum of kidney disease, with a focus on dialysis and rare disease.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Switzerland
Address
Address
Flughofstrasse 61, P.O. Box CH-8152 Glattbrugg
Telephone
Telephone
+41 58 851 80 00
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercepharma.com/pharma/vifor-cut-55-jobs-pa-parent-company-csl-pushes-ahead-downsizing-savings-campaign

FIERCE PHARMA
08 Oct 2025

https://www.prnewswire.com/news-releases/csl-vifor-and-travere-therapeutics-recognize-updated-kdigo-clinical-practice-guidelines-for-iga-nephropathy-302567388.html

PR NEWSWIRE
26 Sep 2025

https://www.prnewswire.com/news-releases/englands-nice-recommends-filspari-sparsentan-as-a-treatment-option-for-iga-nephropathy-302464100.html

PR NEWSWIRE
23 May 2025

https://www.prnewswire.com/news-releases/csl-vifor-and-travere-therapeutics-announce-standard-eu-approval-for-filspari-in-iga-nephropathy-302439782.html

PR NEWSWIRE
29 Apr 2025

https://www.fiercepharma.com/pharma/csl-vifor-floats-ps23m-offer-end-uk-competition-authority-probe-alleged-disinformation

FIERCE PHARMA
11 Dec 2024

https://www.fiercepharma.com/pharma/csl-vifor-floats-ps23m-offer-end-uk-competition-authority-probe-alleged-disinformation

FIERCE PHARMA
10 Dec 2024

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Contact CSL Vifor and get a quotation

CSL Vifor is a supplier offers 6 products (APIs, Excipients or Intermediates).

Find a price of Ferric Carboxymaltose bulk with JDMF offered by CSL Vifor

Find a price of Glycopyrronium Bromide bulk with DMF offered by CSL Vifor

Find a price of Iron Sucrose bulk with DMF offered by CSL Vifor

Find a price of Oxoiron bulk with JDMF offered by CSL Vifor

Find a price of Carboxymethylated Dextran bulk offered by CSL Vifor

Find a price of Iron Dextran bulk offered by CSL Vifor

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty